What has been published
A 2026 systematic review searched four medical databases for published case reports of Wernicke encephalopathy, a serious brain condition caused by thiamine deficiency, in people taking a GLP-1 medication for obesity. It found six cases. All six people had long running stomach symptoms and substantial weight loss before their neurological symptoms began, and several had poor outcomes (Bidesie and Oudman, Obesity, 2026).
A separate 2026 review of nutrient risks on these medications also describes adverse event reports and case reports of Wernicke encephalopathy, linked to prolonged vomiting, poor intake and nutritional compromise (Simancas-Racines and colleagues, Obesity Pillars, 2026).
What these reports cannot tell us
Case reports and adverse event reports can raise a flag. They cannot tell how often something happens, and they cannot prove the medication was the cause. The 2026 review says this directly: spontaneous reporting cannot establish incidence or causality (Simancas-Racines and colleagues, 2026).
Keep the scale in mind too. The NIH says thiamine deficiency is rare in the United States (NIH Office of Dietary Supplements).
The pattern researchers point to
In the published cases, the common thread is long running vomiting or food intake that drops very low. The 2026 review describes the thiamine risk as a complication of very low intake or vomiting, and says it should be considered early when someone has barely been eating for several days (Simancas-Racines and colleagues, 2026).
This is a job for doctors
Serious thiamine deficiency is a medical emergency. The systematic review says early thiamine given by injection or drip is essential to prevent lasting damage (Bidesie and Oudman, 2026). That is hospital care. Do not try to handle it at home.
If you are on GLP-1 medication and cannot keep food down, call your prescriber. For the groups more likely to run low in general, read who is more likely to run low on thiamine. For the wider research, see vitamin B1 on GLP-1 medication, and for your next visit, our prescriber checklist.
Questions
Straight answers
How common is this?
Nobody knows yet. The evidence is case reports and adverse event reports, which cannot measure how often something happens. A 2026 review says prospective studies are needed to find out.
What should I do if I cannot keep food down?
Call your prescriber. If vomiting will not stop, or you notice confusion, trouble walking or changes in your vision, get medical care right away.
Sources for this page
Read them yourself.
Each link opens the original source.
- Wernicke's encephalopathy following semaglutide treatment for obesity: a systematic PRISMA review of case-based evidenceSystematic review, Obesity, 2026. Six published cases, all after long stomach symptoms and weight loss.
- Micronutrient risk with GLP-1 receptor and dual incretin agonists in obesityReview, Obesity Pillars, 2026. Reports cannot establish incidence or causality.
- Thiamin: Fact Sheet for ConsumersNIH Office of Dietary Supplements. Thiamine deficiency is rare in the United States.